| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/16/2005 | US20050132427 Monitoring cell proliferation in rodent animal model after inoculation with tumor cell line; cancer propagation and antiproliferative agents |
| 06/16/2005 | US20050132422 Transgenic flies expressing Abeta42-Iowa |
| 06/16/2005 | US20050132421 Transgenic flies expressing Abeta42-Arctic |
| 06/16/2005 | US20050132332 Multi-location coordinated test apparatus |
| 06/16/2005 | US20050131723 System and method for identifying a food event, tracking the food product, and assessing risks and costs associated with intervention |
| 06/16/2005 | US20050131649 Advanced databasing system for chemical, molecular and cellular biology |
| 06/16/2005 | US20050131648 Screening assays for agonists or antagonists of CD40 signaling |
| 06/16/2005 | US20050131647 Calculating confidence levels for peptide and protein identification |
| 06/16/2005 | US20050131599 Hydraulic fluid change indicating device for automatic transmission |
| 06/16/2005 | US20050131463 Perfusion chamber for recording evoked and spontaneous electrical activity from submerged acute brain slices |
| 06/16/2005 | US20050131314 Methods and apparatus for the rapid detection of microorganisms collected from infected sites |
| 06/16/2005 | US20050131304 Method of assessing skin |
| 06/16/2005 | US20050131219 Methods for reducing complexity of a sample using small epitope antibodies |
| 06/16/2005 | US20050131217 biarsenical molecules such as 4',5'-bis(2-arsa-1,3-dithiolan-2-yl)-3',6'-dihydroxy-3-oxo-spiro(phthalan-1,9'-xanthene); react with 4 cysteine residues of a target peptide; fluorescent signal; kits |
| 06/16/2005 | US20050131216 Reagents for detecting efavirenz |
| 06/16/2005 | US20050131209 Crystallized hnf4 gamma ligand binding domain polypeptide and screening methods employing same |
| 06/16/2005 | US20050131054 Test system for evaluating the compatibility of biologically active substances with copolymers |
| 06/16/2005 | US20050131035 Medicaments |
| 06/16/2005 | US20050131029 Immunophilin ligand treatment of antiretroviral toxic neuropathy |
| 06/16/2005 | US20050131006 Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy |
| 06/16/2005 | US20050131003 Heterocyclic compounds |
| 06/16/2005 | US20050130945 Preventing recurrence of breast cancer with atamestane and toremifene |
| 06/16/2005 | US20050130926 Drug screening; cancer diagnosis; host cells |
| 06/16/2005 | US20050130923 4'-thionucleosides and oligomeric compounds |
| 06/16/2005 | US20050130922 Method and compositions for inhibiting tumorigenesis |
| 06/16/2005 | US20050130910 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; drug screening |
| 06/16/2005 | US20050130904 Therapeutic compositions |
| 06/16/2005 | US20050130899 Tumor antigens |
| 06/16/2005 | US20050130896 Methods and compostions for inhibiting intracellular aggregate formation |
| 06/16/2005 | US20050130890 For N-formylpeptide receptor class receptors, which mediate the inflammation associated with Alzheimer's disease. |
| 06/16/2005 | US20050130876 Use of substances for treating tumors |
| 06/16/2005 | US20050130325 Using fluorescent emission as diagnostic tool in monitoring gene expression analysis |
| 06/16/2005 | US20050130324 Metal nanoshells for biosensing applications |
| 06/16/2005 | US20050130322 Apparatus for monitoring/detecting/determining human chorionic gonadotrophin concentration in fluids; pregnancy testing |
| 06/16/2005 | US20050130320 Using antibody imaging to determine concentration and distribution of proteins in cells and tissues; immunoaffinity chromatography |
| 06/16/2005 | US20050130319 Molecular binding event detection using separation channels |
| 06/16/2005 | US20050130318 Multicompartment apparatus for picking up a plurality of small beads and transferring them to a desired location for use in fabricating arrays on microcards or plates |
| 06/16/2005 | US20050130313 Using tetrahydrofuran as solvent for extraction of low-substituted hydroxypropyl cellulose; using light scattering as tool in determine absolute molecular weight and molecular weight distribution of low-substituted cellulose |
| 06/16/2005 | US20050130312 Method for the detection of compounds comprising methylenedioxyphenyl and testing kit for the same |
| 06/16/2005 | US20050130311 Using follicle stimulating hormone, progesterone and/or estrogen concentrations as indicator tools in detection of sexual disorders |
| 06/16/2005 | US20050130310 Fluid collection apparatus comprising absorbent substrate coated with saccharide for use in monitoring cholesterol concentration in blood |
| 06/16/2005 | US20050130297 Multicompartment apparatus for propagation of preferential tissue; regenerative medicine; tissue engineering |
| 06/16/2005 | US20050130296 Apparatus comprising coated electrodes for use in detecting preferential biopolymers in solution; biosensors |
| 06/16/2005 | US20050130295 Medical apparatus for use in point of care health diagnostics; photocolorimetry; glucose, cholesterol and pregnancy testing |
| 06/16/2005 | US20050130294 Immunoassay; substrate; fluid flow circuits; separation membrane; absorbers; release pads |
| 06/16/2005 | US20050130293 Dry reagent strip configuration, composition and method for multiple analyte determination |
| 06/16/2005 | US20050130286 For diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders |
| 06/16/2005 | US20050130285 Reference solution |
| 06/16/2005 | US20050130270 Use of nucleoside derivatives comprising a citrate group for the production of antibodies having an affinity for triphosphorylated nucleosides |
| 06/16/2005 | US20050130265 Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof |
| 06/16/2005 | US20050130255 Process control based on microbiological activity |
| 06/16/2005 | US20050130254 Apparatus comprising bioscaffold meshwork embedded with cultured liver cell for use toxicity screening tool |
| 06/16/2005 | US20050130250 Using melatonin-signaling impairment as diagnostic indicator bone disorders |
| 06/16/2005 | US20050130247 Rapid prion-detection device, system and test kit |
| 06/16/2005 | US20050130246 Detecting human anti-therapeutic antibodies |
| 06/16/2005 | US20050130245 Using neuronal tissue markers such as glial fibrillary acidic protein (GFAP) as diagnostic tool in detection, prediction, treatment and prevention of pancreatic disorders |
| 06/16/2005 | US20050130244 for detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens |
| 06/16/2005 | US20050130243 For detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens; kits |
| 06/16/2005 | US20050130242 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 06/16/2005 | US20050130241 Immunoglobulin specific for semen constituent for use in diagnosis/prognosis of prostate specific cell proliferative disorders |
| 06/16/2005 | US20050130240 Mannose enclosed metallic nanoparticles for use as diagnostic and drug delivery tools |
| 06/16/2005 | US20050130239 Using helicobacter pylori specific imunoglobulins to diagnosis gastrointestinal disorders |
| 06/16/2005 | US20050130238 ErbB surface receptor complexes as biomarkers |
| 06/16/2005 | US20050130237 Using transgenic cell as tool in determining toxicity of therapeutic agents; drug screening |
| 06/16/2005 | US20050130236 Multi-component test strip for analyzing a plurality of blood components in a single blood sample; blood characterization |
| 06/16/2005 | US20050130235 Method and compositions for the detection of protein glycosylation |
| 06/16/2005 | US20050130234 Method for characterization of abnormal cells |
| 06/16/2005 | US20050130233 Using enhanced neurotrophin-3 expression/activity as diagnostic/prognostic indicator of nervous system disorders |
| 06/16/2005 | US20050130232 Identifying modulators of nuclear hormone activity for use as treatment of skin and cell proliferative disorders |
| 06/16/2005 | US20050130231 Using blood mononuclear cells as tool in monitoring immunological response to plant extracts; drug screening; side effect reduction; ginseng and cancer treatment |
| 06/16/2005 | US20050130230 Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof |
| 06/16/2005 | US20050130229 Representing data from experiments on related combinatorial libraries; rational drug design and data management |
| 06/16/2005 | US20050130226 Fully integrated protein lab-on-a-chip with smart microfluidics for spot array generation |
| 06/16/2005 | US20050130225 Ecstasy haptens and immunogens |
| 06/16/2005 | US20050130224 Computer software and models for determining ligand interaction and secondary structure of proteins |
| 06/16/2005 | US20050130223 Method, system and kit for detecting an analyte in a sample |
| 06/16/2005 | US20050130222 Support apparatus comprising porous monilith for use in matrix-assisted laser desorption/Ionization mass spectrometry (MALDI); biopolymer analysis |
| 06/16/2005 | US20050130220 High speed drug screening; (near) infrared spectrometry, nuclear magnetic resonance, X-ray diffractometry, neutron diffractometry, light/electron microscopy, harmonic generation, circular/linear dichroism spectrometry, differential scanning calorimetry |
| 06/16/2005 | US20050130218 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/16/2005 | US20050130217 Using signal intensity of hybridized oligonucleotides to identify chromosomal amplification and deletions in genome; predicting genomic complexity |
| 06/16/2005 | US20050130215 Using weighted color ratio to accurately determine gene expression patterns; bioinformatics |
| 06/16/2005 | US20050130214 Detecting binding events between biopolymer pairs; biomedical testing systems; drug screening |
| 06/16/2005 | US20050130212 Digital representation of interacting biochemical pathways; bioinformatics; cancer diagnostics |
| 06/16/2005 | US20050130208 Displacement assay for detection of small molecules |
| 06/16/2005 | US20050130207 Cluster complex or colloid comprised of metal core particle and probes for visualizing the localization or distribution of substances within cells, tissue sections, organelles or organs |
| 06/16/2005 | US20050130206 Antiinflammatory ligand for use in prevention and treatment of intestinal ischemia, salmonellosis and/or sepsis |
| 06/16/2005 | US20050130203 Novel GABAB receptor DNA sequences |
| 06/16/2005 | US20050130202 Using presence of microsatellite sequences in mitochondrial polymerase g (POLG) gene as tool in detection and treatment of reproductive disorders |
| 06/16/2005 | US20050130199 Mutations in WNT-frizzled signaling pathways associated with osteoarthritis |
| 06/16/2005 | US20050130197 Homogeneous fluorescence polarization assay for high throughput screening |
| 06/16/2005 | US20050130193 Methods for detecting, diagnosing and treating human renal cell carcinoma |
| 06/16/2005 | US20050130192 Apparatus and method for identifying therapeutic targets using a computer model |
| 06/16/2005 | US20050130191 forming multibranched polyamide amine dendrimer molecules on walls of a U-shaped flow channel through which a solution containing target DNA is flowed;binding probe DNA to tips of said multibranched polyamide amine dendrimer molecules; andextracting said target DNA by hybridization with probes |
| 06/16/2005 | US20050130190 Mutations in ion channel proteins associated with sudden cardiac death |
| 06/16/2005 | US20050130189 Using chromic visceral hypersensitivity (CVH) polypeptide concentration as diagnostic tool in detection of inflammatory disorders |
| 06/16/2005 | US20050130188 Methods for detecting target analytes and enzymatic reactions |
| 06/16/2005 | US20050130187 Using transcriptional patterning to classify preferential gene groupings; computer modeling and genetic analysis |
| 06/16/2005 | US20050130184 Expression vector comprising coded looped RNA sequences for use in the prevention and treatment nervous system disorders; RNA interference |
| 06/16/2005 | US20050130182 Comparing: abundance of one or more marker polypeptides selected from the group consisting of: fibrinogen alpha -chain, fibrinogen beta -chain, fibrinopeptide A, in a patient sample, the normal abundance of the one or more of marker polypeptides in a sample from a control not afflicted with endometriosis |
| 06/16/2005 | US20050130179 Charge tags and the separation of nucleic acid molecules |